The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Paul S. Aisen

University of California San Diego

San Diego

USA

[email]@georgetown.edu

Name/email consistency: high

[Claim this account]

Affiliations

University of California San Diego, San Diego, USA. 2008
Department of Neurology, Georgetown University, Washington, DC 20057, USA. 2002 - 2007

References

Leon Thal and the therapeutic age of Alzheimer's disease. Aisen, P.S. Alzheimer's & Dementia : J. Alzheimer's Association (2008) [Pubmed]
Alzhemed: a potential treatment for Alzheimer's disease. Aisen, P.S., Gauthier, S., Vellas, B., Briand, R., Saumier, D., Laurin, J., Garceau, D. Curr. Alzheimer. Res (2007) [Pubmed]
Commentary on "The Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, 2006."--an appraisal. Aisen, P.S. Alzheimer's & Dementia : J. Alzheimer's Association (2007) [Pubmed]
Development of a disease-modifying treatment for Alzheimer's disease: Alzhemed. Aisen, P.S. Alzheimers. Dement (2006) [Pubmed]
Commentary on "Challenges to demonstrating disease-modifying effects in Alzheimer's disease clinical trials". Aisen, P.S. Alzheimer's & Dementia : J. Alzheimer's Association (2006) [Pubmed]
The development of anti-amyloid therapy for Alzheimer's disease : from secretase modulators to polymerisation inhibitors. Aisen, P.S. CNS. Drugs (2005) [Pubmed]
Can rofecoxib delay a diagnosis of Alzheimer's disease in patients with mild cognitive impairment?. Aisen, P.S. Nature Clinical Practice. Neurology (2005) [Pubmed]
Steroid-induced elevation of glucose in Alzheimer's disease: relationship to gender, apolipoprotein E genotype and cognition. Aisen, P.S., Berg, J.D., Craft, S., Peskind, E.R., Sano, M., Teri, L., Mulnard, R.A., Thomas, R.G., Thal, L.J. Psychoneuroendocrinology (2003) [Pubmed]
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. Aisen, P.S., Schafer, K.A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K.L., Farlow, M.R., Jin, S., Thomas, R.G., Thal, L.J. JAMA (2003) [Pubmed]
Randomized pilot study of nimesulide treatment in Alzheimer's disease. Aisen, P.S., Schmeidler, J., Pasinetti, G.M. Neurology (2002) [Pubmed]
Anti-inflammatory agents in Alzheimer's disease. Aisen, P.S. Curr. Neurol. Neurosci. Rep (2002) [Pubmed]
The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease. Aisen, P.S. Lancet. Neurol (2002) [Pubmed]